Top 10 Benefits of Growth Factor Concentrate Hair Treatment Pune for Natural Hair Regrowth
October 16, 2026
No Comments
Read More »
Written by: Dr. Kiran Chotaliya Editorial Team · Reviewed by: Dr. Kiran Chotaliya, M.D. Dermatologist & Chief Hair transplant Surgeon · Hairfree & Hairgrow Clinics, India · Updated Oct 2026
This case study documents the 27-month treatment journey of a 20-year-old female patient diagnosed with alopecia areata. Before beginning treatment, the patient presented with extensive scalp hair loss with almost complete scalp exposure.
According to the provided patient profile, there was no significant medical history, and the treatment plan included Kenacort Injection along with Excimer Light therapy. Serial clinical photographs document progressive hair regrowth at approximately 1, 3, 5, 8, 11, 13, 17, 19, and 27 months.
The structure below follows the same detailed clinical case-study format as the reference document, including patient profile, clinical assessment, treatment plan, month-wise progress, outcome, maintenance, disclaimer, and FAQs. Pasted markdown
Patient Consent Notice
This case study has been published with the patient’s informed consent for educational and informational purposes. Appropriate measures have been taken to maintain patient privacy while presenting the scalp condition, treatment process, and documented clinical progress.
Individual outcomes with alopecia areata treatment may vary considerably. Hair regrowth can depend on disease activity, extent of hair loss, duration of the condition, individual response to treatment, recurrence, and other biological factors.
The results shown in this case should not be considered a guarantee of similar results for every patient.
Patient Case Overview
Patient Details | Information |
Age | 20 years |
Gender | Female |
Diagnosis | Alopecia Areata |
Medical History | No significant medical history reported |
Initial Condition | Extensive scalp hair loss with marked scalp exposure |
Affected Area | Scalp |
Treatment Plan | Kenacort Injection + Excimer Light |
Treatment Approach | Combination dermatologist-directed treatment |
Documented Follow-Up | 1, 3, 5, 8, 11, 13, 17, 19 and 27 months |
Latest Documented Progress | 27 months |
Before starting treatment, the patient’s clinical photographs showed extensive scalp hair loss with very limited visible hair remaining.
The baseline photographs demonstrated:
This baseline was used to document and compare subsequent treatment response.
Clinical Assessment The patient was clinically assessed for alopecia areata based on the extent and distribution of scalp hair loss.
The assessment focused on:
Serial photographs were used throughout the follow-up period to objectively document visible changes, similar to the photographic monitoring approach used in the supplied case-study format. Pasted markdown
|
Parameter
|
No. of Grafts
|
Details
|
|---|---|---|
|
|
530
|
For natural hairline
|
|
|
2480
|
Mid scalp coverage
|
|
|
3010
|
|
Following clinical evaluation, the patient was advised a combination treatment plan consisting of:
Kenacort Injection + Excimer Light Therapy
The treatment was planned and monitored according to the patient’s clinical presentation and response.
Treatment Goals
The treatment plan focused on:
Kenacort contains triamcinolone, a corticosteroid that may be used intralesionally by dermatologists in selected cases of alopecia areata.
The amount, concentration, injection sites, intervals, and total number of treatments should be individualized according to the patient’s condition and clinical response. The supplied reference case likewise emphasizes that corticosteroid treatment parameters should be decided by the treating dermatologist. Pasted markdown
Clinical follow-up assessed:
Excimer Light was included as part of the patient’s combination treatment plan.
Treatment was directed toward the affected scalp according to the dermatologist’s clinical assessment.
During follow-up, the patient’s response was assessed through:
The combination treatment was followed over an extended period, and the photographic sequence shows that regrowth occurred progressively over several months rather than immediately.
At baseline, the patient showed extensive scalp hair loss with almost complete scalp exposure.
The initial photographs demonstrated:
This stage served as the baseline for evaluating later improvement.
At approximately 1 month, the scalp remained largely visible; however, the photographs show the beginning of very fine and short hair growth across portions of the scalp.
Observed changes included:
This was a very early treatment stage and did not represent the final result.
At the 3-month follow-up, visible hair growth had become more noticeable.
Compared with baseline:
The photographs indicated that active regrowth was developing, although the patient remained at an early stage of recovery.
By approximately 5 months, the patient showed further improvement.
Visible changes included:
Some scalp remained visible because the new hairs were still developing in density and thickness.
At the 8-month follow-up, a substantial change was visible compared with baseline.
The photographs demonstrated:
By this stage, the hair had developed enough to create a noticeably more complete scalp appearance.
At approximately 11 months, the patient’s photographs showed further improvement in overall hair density.
Visible observations included:
The hair had also become longer, making the improvement increasingly noticeable.
At the 13-month follow-up, continued maturation of the regrowing hair was documented.
The photographs showed:
The patient’s natural hair texture had become increasingly evident as the regrowing hair gained length.
At approximately 17 months, the patient’s hair showed further growth in both length and overall volume.
Observed changes included:
Compared with baseline, the difference in scalp coverage was substantial.
At the 19-month follow-up, hair growth remained visibly well established.
Clinical photographs demonstrated:
At this stage, the patient’s hair appeared substantially more mature than during the early treatment months.
At the 27-month documented follow-up, the photographs show extensive scalp hair coverage compared with the baseline condition.
Visible observations include:
The before-and-after comparison is particularly notable because the pretreatment photograph showed almost complete scalp exposure, whereas at 27 months the scalp demonstrated extensive visible hair coverage.
The 27-month stage represents the latest documented follow-up, rather than a guarantee of permanent disease remission.
Treatment Stage | Observed Progress |
|---|---|
Before Treatment | Extensive scalp hair loss with almost complete scalp exposure |
1 Month | Very early fine and short hair beginning to appear |
3 Months | Developing regrowth across multiple scalp areas |
5 Months | Progressive increase in visible hair and scalp coverage |
8 Months | Significant improvement in coverage and reduced scalp visibility |
11 Months | Increasing density and more mature hair growth |
13 Months | Continued maturation, length and improved volume |
17 Months | Strong long-term regrowth with substantial scalp coverage |
19 Months | Continued growth, density improvement and hair maturation |
27 Months | Latest documented stage with extensive mature hair coverage |
The patient’s serial photographs demonstrate progressive visible hair regrowth over the 27-month documented treatment journey.
At baseline, the scalp showed extensive hair loss with almost complete exposure. During the first few months, fine and short regrowing hairs gradually appeared.
The progression became increasingly noticeable between the 5- and 8-month stages, with substantially greater scalp coverage.
During the later follow-up stages:
By 27 months, the photographic follow-up demonstrated a major visible difference compared with the pretreatment condition.
As with the reference case-study format, long-term monitoring remains important because alopecia areata may have an unpredictable clinical course. Pasted markdown
Long-term follow-up remains important even after substantial visible regrowth.
General dermatologist-directed care may include:
The reference format similarly emphasizes regular monitoring and not independently repeating or discontinuing corticosteroid treatment. Pasted markdown
The patient’s documented treatment plan included Kenacort Injection combined with Excimer Light therapy, as advised according to the clinical assessment.
Very early fine hair was visible during the 1-month follow-up, with increasingly noticeable coverage at the 3- and 5-month stages.
In the supplied photographic sequence, a substantial improvement in coverage was visible by approximately 8 months, with continued maturation during later follow-ups.
Dr. Kiran Chotaliya is a leading hair transplant surgeon in Pune, specializing in advanced techniques like FUE and FUT for natural, lasting results. His expertise and patient-centered care ensure successful hair restoration with exceptional outcomes.
© 2026 Developed & Handle By Dr. Kiran Chotaliya Clinic Team
© 2026 Developed & Handle By Dr. Kiran Chotaliya Clinic Team